Professional Documents
Culture Documents
Coe S. Tolosa MD
FLUID AND BLOOD REPLACEMENT
• Guided by manifestations based on amount of
blood volume loss
– <15%% (≤750cc)
• no measurable change in BP, PR or RR
– 15-25% (750-1500cc)
• PR >100/min, BP normal, with orthostatic change, RR,
urine output 20-30ml/hr, anxious VOLUME
REPLACEMENT
– 30-40% (1500- 2000cc)
• PR>120/min, hypotension, tachypnea, urin eoutput 5-
15h/hr, confused
– >40% (>2000cc)
• PR >140/min, hypotension, marked tachypnea, anuria,
lethargic, obtunded BLOOD TRANSFUSION
Unique features considered in
Pregnancy
• Because of blood volume may lose up to
20% of her blood before clinical signs are
apparent
• In volume-contracted cases, patient is more
vulnerable
• Bec of blood flow to gravid uterus, large
amount of blood may be lost rapidly
– > CAN GO TO SUDDEN DECOMPENSATION
AND EXSANGUINATE
Flexibility should be exercised in the application
of guideline and blood transfusion may be
initated prior deterioration of vital signs when
blood loss remains unabated
Management: GENERAL
• SYMPTOMS
– Vaginal Bleeding
– Hypogastric pains
– Passage of meaty tissues
• SIGNS
– Cervix dilated
– Placental tissues at os
– Uterine size incompatible
Diagnosis
• CLINICAL
• History of amenorrhea, bleeding with
expulsion of meaty tissues
• Laboratory Tests
• CBC
• Blood Typing
• If unsure on retention and no
evidence of tissue at os TVS
Management
• IV Fluid
– D5LRS 1L + 10 u Oxytocin at 25-30 gtts/min
• Evacuate the tissues at os
• Sedate or analgesia or anesthesia instituted
• Curettage
• Optional broad spectrum antibiotics on high risk
patients
• Optional Oxytocin Tablet for the first
24 hours
Complete Clinical Assesment
Review History: Length of amenorrhea/LMP, duration and amount of bleeding, duration and severity of
Presentation cramping, abdominal pain, shoulder pain, drug allergies
Cleaned pad, not soaked after 5 Physical Exam: Vital signs, heart, lung, abdomen, Extremities
mins
Indication of systemic problem (shock, sepsis etc)
Fresh blood, no clots
Pelvic Exam: Uterine size, stage of abortion, uterine position
Mixed with mucus
Other: Remove any visible products of conception in the os
Determine ABO type
Restrict to bedrest
Reevaluate after 2
weeks or sooner if
bleeding increases FIRST TRIMESTER SECOND TRIMESTER
Antibiotics if with signs of infection Antibiotics if with signs of infection
Pain control as needed Pain control as needed
Vacuum aspiration or D&C Uterotonic or Instrumental Curettage
Complete Clinical Assesment
Review History: Length of amenorrhea/LMP, duration and amount of bleeding, duration and severity of
Presentation cramping, abdominal pain, shoulder pain, drug allergies
Cleaned pad, not soaked after 5 Physical Exam: Vital signs, heart, lung, abdomen, Extremities
mins
Indication of systemic problem (shock, sepsis etc)
Fresh blood, no clots
Pelvic Exam: Uterine size, stage of abortion, uterine position
Mixed with mucus
Other: Remove any visible products of conception in the os
Determine ABO type
Restrict to bedrest
Reevaluate after 2
weeks or sooner if
bleeding increases FIRST TRIMESTER SECOND TRIMESTER
Antibiotics if with signs of infection Antibiotics if with signs of infection
Pain control as needed Pain control as needed
Vacuum aspiration or D&C Uterotonic or Instrumental Curettage
FIRST TRIMESTER SECOND TRIMESTER
Antibiotics if with signs of infection Antibiotics if with signs of infection
Pain control as needed
Pain control as needed
Vacuum aspiration or D&C
Uterotonic or Instrumental Curettage
• Mild </= 8
• Moderate 9-19
• Severe >/= 20
• The infection should be considered severe in
the presence of the ff regardless of the score
unless secondary to blood loss:
• a. hypotension + tachycardia
• b. tachypnea RR >24
• MILD
– Pen G 4 million IV q6
• MODERATE
– Pen G 4 million IV q6 + Aminoglycoside
• SEVERE
– Pen G 4 million IV q6
– Aminoglycoside
– Metronidazole 500 mg TID IV or PO
Other antimicrobials
- Doxycycline 200mgIV q12hours x 3 days, then
100mg q12hrs x 11days
- Piperacillin 4g IV every 6 hours
- Meropenem 500mg IV every 8 hrs
- Ertapenem 1g IV once a day
- Cefoxitin 2g IV every 6 hours
- Cefotetan 2g IV every 12 hours
- Or Monotherapy w/Moxifloxacin 400mg IV OD
• Additional Regimens
- ATS 3000 IU IM ANST + TT 1cc IM
Assess Severity
Mild </= 8
Moderate 9-19
Severe >/= 20
B. Vaccination – ATS + TT
C. Consider steroids in
severe form
ECTOPIC PREGNANCY
• Pregnancy that develops after implantation of
the blastocyst anywhere else other than the
endometrial lining of the uterine activity
•
• Majority in the fallopian tube (mainly in the
ampulla)
• RISK FACTORS:
- Tubal Pathology •Salpingitis
•Salpingitis Isthmica Nodosa
- Contraception Failure •Previous
•PostAbdominal Surgery not
Tubal Sterilization
•Usethe
involving of fallopian
Copper Ttube
380 IUD
- Hormonal Alterations •Previous
•Progestin
Tubal levels
•Increase Surgery
only contraceptives
of Estrogen and
•Previous
•Progesterone
Ectopic Pregnancy
Progesteron releasing
interfere IUDtubal
with
- Previous abortion •Exposure to DES in utero
motility
•IVF and embryo transfer
- Cigarette smoking
- Abnormal embryonic development
- Increasing maternal age
Clinical Manifestations
• Symptoms • Signs
– Abdominal pain – Adnexal tenderness
– Amenorrhea
– Abdominal tenderness
– Vaginal Bleeding
– Dizziness, fainting – Adnexal mass
– Shoulder tip pain – Uterine enlargement
– Urge to defecate – Orthostatic changes
– Pregnancy symptoms – Fever
– Passage of Tissue
Diagnosis
• Clinical
• Laboratory Test/Procedures
• Diagnostic Procedures
Diagnosis
• Clinical
• Laboratory Test/Procedures
• Diagnostic Procedures
• Clinical
– TRIAD: Pain + Amenorrhea + Vaginal Bleeding
– May present with
• Nausea, breast fullness, fatigue, low abdominal pain,
heavy cramping, shoulder pain, recent dyspareunia
– Physical findings
• Pelvic tenderness, enlarged uterus, adnexal mass and
tenderness
Diagnosis
• Clinical
• Laboratory Test/Procedures
• Diagnostic Procedures
• Laboratory Test/Procedures
– B-HCG
• Positive pregnancy test
– Serial serum levels DO NOT double every two days
– Levels lower than 3000 mIU/ml
– Hematocrit less than 30% in ruptured ectopic
– Leukocyt count normal to mild elevation
– Progesterone
• Level of 5-25ng/ml may indicate nonviable pregnancy
– Under research
• Serume estradiol, inhibin, pregnancy associated plasma protein
A,pregnanediol glucoride, placental
proteins, creatinine kinase, quadruple screen
• Laboratory Test/Procedures
– Ultrasonography
• Complex and cystic adnexal mass or visualization of
an embryo or placenta
• TVS shows absence of intrauterine gestational sac
when gestation is known to be >38 days or B-HCG
is above 1500-2500mIU/ml
• Abdominal ultrasound shows absence of
intrauterine gestation sac when B –HCG is above
6000-6500mIU/ml
• Color doppler flow – demonstrates a 20%
difference in degree of tubal flow between the
adnexae as compared to less than 8% difference in
intrauterine pregnancies
Diagnosis
• Clinical
• Laboratory Test/Procedures
• Diagnostic Procedures
• Diagnostic Procedures
– Culdocentesis
• Inserting a needle through the posterior fornix of the
vagina into the cul de sac and aspirating nonclotting
blood
– Laparoscopy
• Direct assessment
• Provides the option to treat once diagnosis is
established
– Dilatation and Curettage
• No chorionic villi obtained should raised
suspicion of a possible ectopic pregnancy
Management
• Criteria
• Approach
• Procedures
• Criteria
– Woman NOT hemodynamically stable
– Does NOT fulfill criteria for medical management
• Approach
– LAPAROSCOPIC
• Hemodynamically stbale
• Less blood loss, shorter hospital stay, lower analgesic
requirements
• Shorter operation times in skilled surgeons
• Similar intrauterine pregnancy rates
– LAPAROTOMY
• NOT hemodynamically stable
• When laparoscopy is difficult dense adhesions,
massive hemoperitoneum
• Surgeon lacking skills
• PROCEDURES
– RADICAL
• SALPINGECTOMY
– Resection of tubal segment containing gestation
– Performed if:
» Tube is severely damaged
» There is uncontrolled bleeding
» Recurrent ectopic pregnancy in same tube
» Large tubal pregnancy >5cm
» Woman has completed pregnancy
• CORNUAL RESECTION of an interstitial pregnancy
• HYSTERECTOMY for interstitial pregnancy
• PROCEDURES
– CONSERVATIVE
• Preserve tubal function in women desiring future fertility
• SALPINGOTOMY tubal incision closed primarily
• SALPINGOSTOMY tubal incision allowed to closed by
secondary intention
• FIMBRIAL EVACUATION
– Blunt curettage or digital expression (milking)
– Associated with high rate of recurrent ectopic pregnancies,
bleeding and tube damage
– May not remove entire tubal gestation
• SEGMENT RESECTION of tubal segment
– May be candidates for delayed microsurgical
reanastomosis
Abdominal pain
Algorithm I: Vaginal Bleeding
Missed Period
TVS
MEDICAL
SURGICAL
Methotrexate
Single/Multiple dose regimen
Unstable Stable
Monitor B-HCG Dense Adhesions
Increase laparotomy
Salpingectomy
Hysterectomy
Algorithm I:
Management Conservative
Day 7 B-HCG >1000ml mIU/ml or >15% level of initial level Monitor B-HCG weekly
Day 9 B-HCG >10% of initial
Day 0 serum progesterone >1.5ng/ml
Decrease by at least 15%
Persistent Ectopic
Pregnancy Continue monitoring until
<5 mIU/ml
Salpingectomy
Salpingostomy
Methotrexate
Expectant
ABRUPTIO PLACENTA
ABRUPTIO PLACENTA
+ FHT - FHT
Reassuring Nonreassuing Fetal status Stable maternal condition Unstable maternal condition
Term Fetus Unstable maternal Normal Bleeding Abnormal Bleeding
condition Parameters Parameters
Stable maternal condition
VAGINAL DELIVERY
• Risk Factors
• Advancing age (>35)
• Multiparity
• Prior Cesarean Section
• Multiple Gestation
• Recurrent abortions
• History of dilatation and curettage
• Smoking
Clinical Manifestation
MANNER OF DELIVERY
Previa Totalis Placental edge >/= 2cm from Placental edge <2cm
the os from the os
• Risk Factors
• Previous Cesarean Section
• Placenta Previa
• Advanced Maternal Age
Diagnosis
•Hysterectomy
•Conservative Surgery if Feritlity preservation desired
PRESENCE OF RISK FACTORS
PLACENTA •Previous Cesarean Section
•Placenta Previa
ACCRETA •Advance Maternal Age
•Hysterectomy
•Conservative Surgery if Feritlity preservation desired
Complications
• Intrapartum/Postpartum Hemorrhage
• SHOCK (with or without Panhypopituitarism)
• Severe Anemia
• Puerperal Sepsis
• Hysterectomy
RETAINED PLACENTA
RETAINED PLACENTA
PLACENTA
w/ Bleeding w/o bleeding
•Contraction Ring •Complete Placenta Accreta
•Atonic Uterus
•Partial Placenta Accreta
•Oxytocin IM
•Push Placenta towards the vagina Placenta NOT detached, Manual Removal under
Anesthesia
•Deliver Placenta by twisting while pulling
constantly
Hysterectomy
Diagnosis
• CLINICAL
• LABORATORY TEST
Diagnosis
• CLINICAL
1. Presence of Contraction ring if
• Sudden gush of blood
• Fundus moves higher and becomes globular
• Increase in cord length at the vulva
• Raising of the fundus does not cause
shortening of the cord
2. Absence of the above may indicate presence of
PLACENTA ACCRETA
Diagnosis
• LABORATORY TEST
• Ultrasonography can identify placenta
accreta
Management
• Bladder is Emptied
• IF PLACENTA HAS SEPARATED
• Deliver placenta by “rubbing up” uterus or
give Oxytocin
• Push placenta toward the vagina to help
with expulsion
• Placenta is held and twisted whilst pulling
constantly
Management
PLACENTA
w/ Bleeding w/o bleeding
•Contraction Ring •Complete Placenta Accreta
•Atonic Uterus
•Partial Placenta Accreta
•Oxytocin IM
•Push Placenta towards the vagina Placenta NOT detached, Manual Removal under
Anesthesia
•Deliver Placenta by twisting while pulling
constantly
Hysterectomy
• When placenta is fully detached explore uterine cavity for
damage and other pieces
• ALTERNATIVE MANAGEMENT
• Inject saline 20ml + 10 u Oxytocin into
the Umbilical vein
• If due to Hour-Glass Contraction ring
• Deepen anesthesia (HALOTHANE useful,
subcutaneous injection of 0.5ml in 1000
Adrenaline HCL or Inhalation of 2 amyl
nitrate capsule
• If ring Is too tight, proceed to manual
exploration and manual extraction
Bleeding Controlled
Bimanual/Aortic Compression
Laparotomy Reproductive
Preservation desired
Bleeding
Bleeding Controlled Controlled Uterine/Ovarian ligations Uterine Compression
Sutures
Bleeding Persists
Bleeding Persists
Bleeding Hysterectomy
Controlled
Hysterectomy
Bleeding
•Close surveillance and Oxytocin for 24 hours Controlled
•In case of massive blood loss GIVE BLOOD
TRANSFUSION
UTERINE
Early Clinical Diagnosis
INVERSION Rule out a Ruptured Uterus
UTERINE
Early Clinical Diagnosis
INVERSION Rule out a Ruptured Uterus
Manual repositioning in OR
under general anesthesia
•1L of LR + 20u Oxytocin or
(JOHNSON’S METHOD) Methylergometrine IM
Hydrostatic Repositioning
(O’Sullivan’s Technique)
•Single dose of prophylactic
Antibiotics
EXLAP for uterine repositioning by: •Ampicillin 2g IV +
HUNTINGTON’S
•Mechanical pulling up of the fundus from the constrictive ring Metronidazole 500mg IV
(HUNTINGTON’S TECHNIQUE •Two Allis forceps applied on either
•Division of the constrictive ring posteriorly followed by repositioning
•Cefazolin
side of uterus1g
2cmIV below
+ the ring
(HAULTAIN’s TECHNIQUE)
HAULTAIN’S
Metronidazole
and steadyring
•Cervical traction500mg IV
applied.
is incised posteriorly
•Repeated until direction
in the vertical uterus is replaced
until
Hysterectomy
•Acervical
well place traction suture
constriction in the
is removed
fundus will help done.
and reposition
Postoperative management with •Cervical incision sutured
resuscitation, antibiotics and
prostaglanding (if uterus intact)
TRAUMA TO THE GENITAL TRACT
TRAUMA TO THE GENITAL TRACT
• Anatomic disruption
Soft “ boggy uterus Genital Tract Tear Placenta Retained Blood not clotting
Recommendation:
TONE Inversion of Uterus TISSUE THROMBIN
2 large bore IV needle
TRAUMA
Oxygen by mask
Inspect Placenta Observe Clotting
Monitor BP, PR, UO Bimanual Uterine Explore Lower Genital Consider CBC, type
Team approach, call for help massage Tract and Crossmatch,
Coagulation Screed
20 IU L Normal Saline
infused up to 500ml
Consider Exploring the
over 30 minutes
Uterus
LACERATION HEMATOMA
Large/Increasing:
Suture Repair: Suture repair by Evacuation of blood/clots
Layer Ligate bleeders
Anterograde (apex to base)
Antimicrobial Leave drain
Retrograde (base to apex)
Stool Softeners Suture defect compression suture
Antimicrobial
NSAIDS Antimicrobial
NSAIDS
NOTE: Blood loss ≥ 1000ml: Transfuse RBCs, platelets and/or clotting factors and support
blood pressure with vasopressors
CERVICAL LACERATIONS
• Etiology
• Forceps, ventouse or breech extraction
before full dilatation
• Difficult forceps rotaton
• Manual dilatation of the cervix
• Improper use of oxytocins
• Precipitate labor
CERVICAL LACERATIONS
• Predisposing factors
• Cervical rigidity
• Scarring of the cervix
• Edema as in prolonged labor
• Placenta previa due to increased vascularity
CERVICAL LACERATIONS
• Types
• Unilateral: more common in LEFT due to
• Dextrorotation of the uterus
• Left occipitoanterior position is
commonest
• Bilateral
• Stellate: multiple tears
• Annular or circular detachment
CERVICAL LACERATIONS
• Diagnosis
• Excessive hemorrhage inspite of well
contracted uterus
• Vaginal exam: tear can be felt
• Speculum exam for adequate exposure
• RIGBY or GELPI self-retaining retractor + 2
ring forceps
CERVICAL LACERATIONS
• Complications
• Postpartum Hemorrhage
• Rupture due to upward extension
• Infection: Cervicitis and Parametritis
• Cervical incompetence
• Ureteric injury
CERVICAL LACERATIONS
• Management
• Up to 2 cm are inevitable heal rapidly as
long as not bleeding
• Immediate repair
• Assistant applies downwar pressure on
uterus
• Vaginal walls held with retractors
• Interrupted or running sutures from apex
VAGINAL LACERATIONS
• Causes
• Primary Lacerations (less common)
• Forceps application
• Destructive operations
• Vaccum extraction if cup sucks vaginal wall
• Etiology
• Lack of perineal elasticity •Elderly Primigravida
•Excessive scarring
•Allowing due
headtoextension
• Marked perineal stretch •Friability
before crowing
edema
perineal
•Macrosomic baby
• Rapid Perineal Stretch •Face to pubis
•Precipitate delivery
labor
•Forceps delivery
•Rapid delivery of the
•Narrow suprapubic
aftercoming head in angle
breech
pushing heal backward
PERINEAL LACERATIONS
• Complications
• Postpartum hemorrhage
• Puerperal infection
• Incontinence of stool and flatus
• Residual recto-vaginal fistula
• Future genital prolapse
• Dyspareunia due to tender vaginal scar
BRISK BLEEDING Blood los >500ml
BP FAILING
PULSE RATE RISING
Soft “ boggy uterus Genital Tract Tear Placenta Retained Blood not clotting
Recommendation:
TONE Inversion of Uterus TISSUE THROMBIN
2 large bore IV needle
TRAUMA
Oxygen by mask
Inspect Placenta Observe Clotting
Monitor BP, PR, UO Bimanual Uterine Explore Lower Genital Consider CBC, type
Team approach, call for help massage Tract and Crossmatch,
Coagulation Screed
20 IU L Normal Saline
infused up to 500ml
Consider Exploring the
over 30 minutes
Uterus
LACERATION HEMATOMA
Large/Increasing:
Suture Repair: Suture repair by Evacuation of blood/clots
Layer Ligate bleeders
Anterograde (apex to base)
Antimicrobial Leave drain
Retrograde (base to apex)
Stool Softeners Suture defect compression suture
Antimicrobial
NSAIDS Antimicrobial
NSAIDS
NOTE: Blood loss ≥ 1000ml: Transfuse RBCs, platelets and/or clotting factors and support
blood pressure with vasopressors
PUERPERAL VULVAR/VAGINAL
HEMATOMA
• Complications
• INTERMEDIATE disease
DISSEMINATED INTRAVASCULAR
COAGULATION in OBSTETRICS
• Pregnancy predisposes patients to DIC for the
following reasons:
• Pregnancy produces a hypercoagulable state
• Pregnancy is associated with reduced fibrinolytic
activity
• Pregnancy is associated with decline in plasma
level of protein S
Obstetric conditions associated with
DIC
1. Abruptio Placenta •Most common obstetric cause
•Mechanism: Activation of
2. Preeclampsia/Eclampsia EXTRINSIC •Majority
coagulation
will havecascade
subclinical
pathway by TISSUEcoagulopathy
consumptive
3. IUFD •Develops in 25% of dead •Mechanism:
THROMBOPLASTIN
fetus if release from
diminished
retained for >1 monthplacenta
PROSTACYCLIN leads to
4. Septic Abortion
•Mechanism: Activation ofabnormal
•Reported PLATELET
to occur
AGGREGATION
in 31% of pxs
whichreleased
can
EXTRINSIC coagulation•Mechanism:
pathway by ENDOTOXIN
•Occur in 45% of cases who
5. Amniotic FluidTISSUE
embolism
THROMBOPLASTIN initiate
activateds DIC extrinsic
BOTH
survive
released by necrotic fetus into the
clotting
cardivascular insult
mechanism (thru release of tissue
•Mechanism:
maternal circulation factor expression on the surface of
THROMBOPLASTIN from
activated monocytes and
amniotic fluid trigger the
endothelial cells) and intrinsic
EXTRINSIC coagulation
pathway (by activation of factor X.
pathway
Clinical Manifestation
NO YES
STEP 5 if ≥ 5 Step 5 if ≤ 5
DIC
Management Vigorous Treatment of Underlying Disease
Wait for successof treatment but Consider waiting for Consider replacement therapy &/or Consider replacement
be alert for deterioration success of treatment continuous heparin infusion in the ff: therapy only in the ff:
if patient’s condition •Abruptio placenta
•AF embolism
is stable
•Septic abortion •Severe Bleeding